StocksJohnson & JohnsonJNJ

JNJ

Johnson & Johnson

176.98 3.04 (1.75%)
Delayed Prices By NASDAQ, in USD Market Closed
Trade
S
176.80
B
177.18

Overview

Prev Close176.98
Day's Range 173.86 - 176.98
52 Week Range 155.56 - 186.50
Average Volume (3m)7.87M
1-Year Return3.54%
Beta0.5645
Market Cap465.71B
P/E Ratio23.83
Revenue94.9B
EPS7.4254
Dividend (Yield)4.31 (2.44%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Created with Highcharts 4.2.7 /Highstock 4.2.709/12/202118/02/202203/05/2022160.00165.00170.00175.00180.00185.00190.00
Chart times in UTC
Industry Pharmaceuticals Major
CEO Joaquin Duato, MBA
Employees 141,700

FINANCIAL SUMMARY

For the quarter ended 31/3/2022, Johnson & Johnson's revenues decreased by 5.56% and amounted to 23.43B. Net income increased by 8.72% to 5.15B. Net assets decreased by NaN to N/A and EPS increased from 1.77 to 1.93.
JNJ's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Gross Margin
67.96%
Net Profit Margin
15.79%
Operating Margin
25.69%
Return On Investment
14.28%
06/21
09/21
12/21
03/22
Total Revenue
23.31B
23.34B
24.8B
23.43B
Gross Profit
16.93B
17.25B
17.97B
16.94B
Operating Income
6.26B
6.67B
4.98B
6.43B
Net Income
6.28B
3.67B
4.74B
5.15B